GRI Bio, Inc. (GRI) vs Mustang Bio, Inc. (MBIO)

GRI Bio, Inc. and Mustang Bio, Inc. are both Biotechnology companies. GRI Bio, Inc. and Mustang Bio, Inc. are of similar size ($3.1M and $2.9M). Mustang Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. Across the 8 metrics below, GRI Bio, Inc. leads on 4 and Mustang Bio, Inc. on 4.

Valuation

Metric GRI MBIO Biotechnology median
P/E 0.02 n/m 8.50
P/S n/m n/m 9.71
P/B 0.24 0.34 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.86 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 5,408.03% (118.42%) (33.15%)
Free cash flow yield (418.56%) (147.00%) (25.50%)

Profitability

Metric GRI MBIO Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (142.02%) (58.12%) (56.36%)
Return on assets (113.27%) (21.17%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GRI MBIO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 92.12% 98.49% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GRI MBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.30 1.97 4.72
Net debt to EBITDA 0.69 7.22 0.96

Dividend

Metric GRI MBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GRI MBIO Biotechnology median
Market cap 3.06m 2.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack